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INTRODUCTION
Endometrial cancer is the most common malignancy of the 
female reproductive tract in developed countries.1 Most pa-
tients with endometrial cancer present at an early stage; thus, 
surgery is often the first major step in the management of this 
disease. Conventionally, surgery is performed via a midline 
laparotomy, which is known to be associated with substantial 
perioperative morbidity.2,3
Minimally invasive surgery (MIS) provides equivalent onco-
logic outcomes when used for endometrial cancer treatment 
with reduced surgical and postoperative morbidity.4-6 Howev-
er, the well-known steep learning curve of a laparoscopic pro-
cedure restricts its widespread application in the surgical treat-
ment for endometrial cancer. The introduction of robot-assisted 
staging surgery (RSS) with a relatively shallow learning curve 
has facilitated more gynecologic oncologists to employ MIS over 
open surgery when treating endometrial cancer.7,8
Previous research comparing open surgery with laparosco-
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py5,6,9 and laparoscopy with robot-assisted surgery exists,10,11 
along with a meta-analysis comparing all three approaches.12,13 
However, there is a scarcity of data with respect to direct com-
parison of survival outcomes between open surgery and RSS 
using three robotic arms for endometrial cancer.7,14-16 However, 
only few published studies have focused on the placement and 
the number of robotic arms used in the procedure.17-19
Therefore, this research aimed to assess the survival out-
come of RSS using three robotic arms, and to compare it with 
that of staging laparotomy after propensity score matching 
among patients from a single tertiary institution. We hypothe-
sized that RSS with three robotic arms would yield equivalent 




All consecutive patients who underwent open staging laparot-
omy or da Vinci RSS using three robotic arms for endometrial 
cancer between May 2006 and May 2018 at a single institution 
were reviewed. Our research was performed in accordance 
with the ethical tenets of the Declaration of Helsinki, and was 
approved by the Institutional Review Board (IRB) of Yonsei 
University College of Medicine (ethic code: 4-2019-0817). 
Surgery and outcomes 
The mode of surgery was selected mainly based on the sur-
geon’s discretion. Demographic and clinical characteristics 
(age at diagnosis and body mass index), pathological charac-
teristics [histologic type, grade, and the International Federa-
tion of Gynecology and Obstetrics (FIGO) stage], perioperative 
characteristics (surgical approach, type of procedures per-
formed, number of harvested lymph nodes, and conversion to 
laparotomy), adjuvant therapy (radiation, chemotherapy, or 
both), and survival outcomes (recurrence and vital status) were 
collected from the electronic medical records. Disease-free sur-
vival (DFS) was defined as the time interval between the date 
of initial diagnosis and that of disease progression based on the 
Response Evaluation Criteria in Solid Tumours (version 152 
1.1).20 We calculated the overall survival (OS) as the time in-
terval between the date of initial diagnosis and that of cancer-
related death or the end of the study.
All patients underwent complete surgical staging for endo-
metrial cancer, including hysterectomy, salpingo-oophorec-
tomy, lymph node dissection (pelvic with/without paraaortic 
nodes), omentectomy, and peritoneal biopsies when required. 
Robot-assisted surgeries were performed using the da Vinci 
robotic surgical system (Intuitive Surgical Inc., Sunnyvale, CA, 
USA) with the Maryland Bipolar and Permanent Cautery 
Spatula or needle holder on each robotic arm, as described 
previously.17,18 Port placement of the RSS using three robotic 
arms is presented in Fig. 1.
Statistical analyses 
Categorical variables were evaluated using Pearson’s chi-
squared test or Fisher’s exact test depending on the category 
size, whereas Student’s t-test was used for comparing continu-
ous variables. The Kaplan-Meier method was used to estimate 
the survival function. Using the proportional hazards model, 
we estimated the hazard ratios for each of the following vari-
Fig. 1. Port placement in the robot-assisted staging surgery using three robotic arms. A: S/Si model: 3 ports. B: Xi model: 3 ports.
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ables: surgical method, age, FIGO stage, histology, grade, and 
lymph node status. We performed propensity score matching 
to reduce the bias in the estimate of the difference in survival 
after open and robot-assisted surgical staging for endometrial 
cancer. The propensity score model accounted for the surgical 
stage, grade, and histology. To estimate the difference in surviv-
al between the two surgical methods, we constructed a propor-
tional hazards model using the matched data.
RESULTS
Patient characteristics
The flowchart for patient selection is shown in Fig. 2. In total, 
423 patients were identified between May 2006 and May 2018; 
their clinical and pathological characteristics are shown in 
detail in Table 1. Open surgery was performed in 218 (51.5%) 
May 2006–May 2018 
423 unselected patients 
who received staging 
surgery for endometrial cancer
 Propensity-score matching with FIGO stage, grade, and 
 histology
     Laparotomy  Robot- 
           (n=218) assisted surgery 
                       (n=205)
     Laparotomy Robot- 
           (n=146) assisted surgery 
                       (n=146)
Fig. 2. Flowchart of patient selection. FIGO, Federation of Gynecology 
and Obstetrics.
Table 1. Patient Characteristics Before and After PSM
Characteristic
Before PSM After PSM
Laparotomy (n=218) Robotic (n=205) p value Laparotomy (n=146) Robotic (n=146) p value
Age (yr) 55.2 (10.2) 52.8 (9.0) 0.080 54.9 (10.2) 53.4 (8.8) 0.850
BMI (kg/m2) 24.7 (4.8) 24.6 (5.2) 0.880 24.9 (5.1) 24.5 (5.3) 0.340
FIGO stage
I 138 (63.0) 182 (88.8) <0.010 124 (84.9) 124 (84.9) 0.990
II 17 (7.8) 5 (2.4) 5 (3.4) 5 (3.4)
III 42 (19.3) 16 (7.8) 15 (10.3) 15 (10.3)
IV 21 (9.6) 2 (1.0) 2 (1.4) 2 (1.4)
Cell type <0.010 0.990
Endometrioid 147 (67.4) 166 (81.0) 117 (80.1) 117 (80.1)
Other 71 (32.6) 39 (19.0) 29 (19.9) 29 (19.9)
Grade <0.010 0.990
1 73 (33.5) 106 (51.7) 63 (43.2) 63 (43.2)
2 67 (30.7) 64 (31.2) 51 (34.9) 51 (34.9)
3 78 (35.8) 35 (17.1) 32 (21.9) 32 (21.9)
Harvested LN, median (range)
Pelvic LN 16 (2–54) 12 (2–72) 0.990 16 (2–47) 13 (2–46) 0.180
Paraaortic LN 3 (0–51) 3 (0–36) 0.340 3 (0–35) 3 (0–36) 0.550
EBL (cc) 409.6 (614.4) 91.9 (108.2) <0.010 316.8 (333.4) 113.0 (113.0) <0.010
Transfusion 40 (18.3) 11 (5.4) <0.100 9 (6.2) 6 (4.1) 0.420
Conversion to laparotomy 0 0
Adjuvant therapy <0.010 0.020
Radiation 53 (24.3) 27 (13.2) 41 (28.1) 20 (13.7)
Chemotherapy 62 (28.4) 29 (14.1) 20 (13.7) 23 (15.8)
Both 22 (10.1) 7 (3.4) 9 (6.2) 6 (4.1)
None 81 (37.2) 142 (69.3) 76 (52.1) 97 (66.4)
Recurrence <0.010 0.380
No 177 (81.2) 187 (91.2) 128 (87.7) 133 (91.1)
Yes 41 (18.8) 18 (8.8) 18 (12.3) 13 (8.9)
Vital status 0.120 0.770
Alive 190 (87.2) 193 (94.1) 133 (91.1) 135 (92.5)
Dead 28 (12.8) 12 (5.9) 13 (8.9) 11 (7.5)
PSM, propensity score matching; SD, standard deviation; BMI, body mass index; FIGO, International Federation of Gynecology and Obstetrics; LN, lymph node; 
EBL, estimated blood loss.
Data are presented as mean (SD) or n (%).
71
Kyung Jin Eoh, et al.
https://doi.org/10.3349/ymj.2021.62.1.68
Fig. 3. (A) DFS and (B) OS of the propensity score-matched cohort. Five-year DFSs were 86% and 89% in the open and robot-assisted surgical co-
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patients, and 205 (48.5%) underwent RSS using three robotic 
arms. There were no conversions to open laparotomy. After 
propensity score weighting, 146 patients were matched in each 
surgical group, and there was no difference in any of the pa-
tient characteristics, except for the estimated blood loss (EBL) 
and the number of adjuvant treatments (Table 1). EBL was sig-
nificantly higher in the laparotomy group than in the robotic 
surgery group (316.8 cc vs. 113.0 cc; p<0.010), but the number 
of transfusions did not differ between the two groups. A signifi-
cant difference was found in the proportion of patients who 
were treated with adjuvant therapy between the propensity 
score-matched groups (28.1% in open group vs. 13.7% in robot-
ic group; p=0.019). After propensity score weighting, overall, 
31 (10.6%) patients experienced recurrence, and there was no 
difference in this regard between the two groups (p=0.380). 
There were 24 deaths (8.2%) in the entire propensity score-
matched cohort, and no difference was observed between the 
two groups in this regard (p=0.770).
Survival outcome
After propensity score matching that accounted for the FIGO 
stage, grade, and histology, Kaplan-Meier survival analysis 
showed no significant differences in DFS (p=0.695) and OS (p= 
0.487) between the two groups (Fig. 3). The estimated 5-year 
DFS rates were 86% and 89% in the laparotomy and robot-as-
sisted surgical cohorts, respectively. The estimated 5-year OS 
rates were 91% and 92% in the laparotomy and robot-assisted 
surgical cohorts, respectively. 
Univariate and multivariate regression analyses
In the univariate regression analyses of the complete cohort 
with DFS as the endpoint, the mode of surgery, FIGO stage, 
grade, histology, and lymph node metastasis were associated 
with increased risk of recurrence, whereas in the following 
multivariate analysis, only grade 3 (p<0.010) was shown to be 
a significant independent risk factor. When OS was set as the 
endpoint, the mode of surgery, age, FIGO stage, histology, grade, 
and lymph node metastasis were significantly associated with 
worse prognosis in the univariate regression analysis of the 
complete cohort. In the multivariate analysis, FIGO stage IV (p< 
0.01), histology (p=0.010), and grade 3 (p<0.010) were found to 
be significant independent risk factors (Table 2). 
DISCUSSION
The present study compared the survival outcomes between 
open surgery and RSS using three robotic arms in the era of a 
shift in the standard of care in the surgical management of en-
dometrial cancers from open surgery to MIS. We found that 
staging surgery using three robotic arms in robotic surgery did 
not seem to compromise survival outcomes when compared to 
laparotomy for endometrial cancer. To the best of our knowl-
edge, this is the first study to evaluate the survival outcomes be-
tween RSS using three robotic arms and open staging surgery 
for endometrial cancer. In South Korea, where robotic surgery 
is not covered by the National Health Insurance, it is neces-
sary to reduce the economic burden on patients, and finding 
a strategy to reduce cost including using three robotic arms 
would have clinical implication.
The introduction of robot-assisted laparoscopic surgery has 
been shown to increase the application of MIS for malignan-
cies,8,21,22 and MIS has been demonstrated to decrease surgical 
complications.23-26 Specifically, robot-assisted surgery is bene-
ficial for obese patients, as it is correlated with a significantly 
reduced rate of surgical complications than that seen with open 
surgery, as well as a lower rate of conversion to open surgery 
when compared with conventional laparoscopy.27-29 However, 
in terms of the survival outcomes of MIS for endometrial can-
cer, most of the available studies compared open surgery with 
conventional laparoscopy rather than with robotic surgery, and 
indicated that laparoscopy was a favorable option for patients 
with endometrial cancer.4,30,31 In the present study, we compared 
the survival outcomes between propensity score-matched 
72
Robotic Staging Using 3 Arms Versus Open Surgery
https://doi.org/10.3349/ymj.2021.62.1.68
groups of patients undergoing open and robotic surgery using 
three robotic arms after the introduction of robot-assisted lap-
aroscopic surgery. Our results showed that the adoption of ro-
botic surgery did not compromise the survival outcomes, de-
spite the inclusion of the learning curve for all gynecologic 
oncologists.
In the published literature, few studies have reported results 
on comparative long-term oncological outcomes between lap-
arotomy and robotic surgery for endometrial cancer due to lim-
ited data and short follow-up period. Corrado, et al.32 observed 
that the 3-year OS rates were 86.7% and 91.5% and the 3-year 
DFS rates were 92.1% and 91.5% following open and robotic 
surgeries, respectively. Likewise, Cardenas-Goicoechea, et al.33 
showed that there were no significant differences in survival 
between robotic and laparoscopic surgeries (3-year OS: 93.6% 
and 93.3%, and 3-year DFS: 88.4% and 83.3%, with convention-
al laparoscopy and robotic surgery, respectively). Moreover, 
Brudie, et al.34 reported a 3-year DFS of 89.3% and a 3-year OS 
of 89.1%, and Kilgore, et al.35 noted a 5-year OS of 89.1% in pa-
tients who underwent robotic surgery for endometrial cancer. 
Compared with the previous reports, we demonstrated compa-
rable survival outcomes (5-year DFS: 89% and 5-year OS: 92%) 
in the robotic surgery group when using the equipment with 
three robotic arms in this study.
The use of three robotic arms is unique, since most other 
studies on robotic gynecologic surgery used four robotic arms 
for staging surgery for endometrial cancer. The use of three ro-
botic arms at our institution is mainly due to cost consider-
ations. The highly cost-intensive nature of robotic surgery is a 
major obstacle in determining the robotic surgical mode and 
conducting a randomized clinical trial. Currently, the cost for 
robotic surgery is not reimbursed by the National Health In-
surance in South Korea; therefore, patient expenses for robot-
ic surgery are approximately four times higher than that for 
conventional laparoscopic or open surgery. It has been previ-
ously reported that eliminating one robotic arm may allow the 
patient to save approximately US$500.18 Since the introduc-
tion of the robotic surgical system in our institution, we have 
used three robotic arms for performing robotic surgeries, and 
have not encountered or observed major technical difficulties 
or perioperative complications.
The strength of our study was that all surgical procedures and 
adjuvant treatments were conducted at a single institution by 
fellowship-trained gynecologic oncologists and designated ra-
diation oncologists. Despite this strength, our study also had 
some limitations, including the retrospective nature of the study 
and unmeasured variables that can cause confounding. In ad-
dition, potential selection bias, especially that owing to the se-
lection of patients who can undergo robotic surgery, may also 
exist. Due to the small sample size, further investigation is cur-
Table 2. Univariate and Multivariate Analyses of the Complete Cohort (n=423) with DFS and OS as Endpoints
Variables
DFS OS
Univariate analysis Multivariate analysis Univariate analysis Multivariate analysis
HR (95% CI) p value HR (95% CI) p value HR (95% CI) p value HR (95% CI) p value
Surgical mode
Laparotomy 1.00� 1.00� 1.00� 1.00�
Robot 0.43 (0.25–0.76) <0.001 1.03 (0.56–1.91) 0.901 0.42 (0.21–0.82) 0.010 0.92 (0.42–1.97) 0.830
Age (yr)
≤49 1.00� 1.00� 1.00� 1.00�
≥50 1.31 (0.72–2.40) 0.360 1.03 (0.56–1.91) 0.192 2.36 (0.99–5.63) 0.052 2.09 (0.85–5.12) 0.103
FIGO stage 
I 1.00� 1.00� 1.00� 1.00�
II 3.85 (1.58–9.41) <0.001   1.99 (0.21–18.83) 0.543 2.85 (0.83–9.75) 0.087   1.52 (0.07–30.88) 0.780
III 3.633 (1.88–7.01) <0.001 0.47 (0.50–4.50) 0.831 3.12 (1.34–7.29) <0.001   0.45 (0.00–25.01) 0.898
IV 19.36 (9.94–37.69) <0.001 11.51 (5.49–24.14) <0.001 19.69 (9.20–42.10) <0.001 11.27 (4.80–26.43) <0.001
Histology
Endometrioid 1.00� 1.00� 1.00� 1.00�
Other 3.44 (2.05–5.77) <0.001 1.44 (0.79–2.63) 0.223   5.60 (2.95–10.61) <0.001 2.47 (1.17–5.24) 0.012
Grade
1 1.00� 1.00� 1.00� 1.00�
2 2.16 (0.94–4.95) 0.058 1.82 (0.78–4.23) 0.151 3.11 (0.97–9.92) 0.053 2.62 (0.81–8.44) 0.062
3   7.39 (3.54–15.39) <0.001 3.68 (1.61–8.39) <0.001 11.82 (4.11–33.92) <0.001   4.59 (1.45–14.49) <0.001
LN metastasis
Negative 1.00� 1.00� 1.00� 1.00�
Positive 5.36 (3.12–9.20) <0.001 1.68 (0.69–4.03) 0.122   6.16 (3.22–11.77) <0.001 1.56 (0.51–4.70) 0.430
DFS, disease-free survival; OS, overall survival; HR, hazard ratio; CI, confidence interval; FIGO, International Federation of Gynecology and Obstetrics; LN, lymph 
node.
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rently underway to determine whether the main findings of this 
study are comparable to those obtained when data collected 
from a large national database are analyzed.
In conclusion, our data suggested that robotic staging sur-
gery using three robotic arms and laparotomy for endometrial 
carcinoma had equivalent survival outcomes. Long-term fol-
low-up and multicenter investigations are required to confirm 
the result of this study as well as its generalizability.
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